Aileen Anderson

Vice Chancellor of Research

  • Irvine CA UNITED STATES

Aileen Anderson is an expert on stem cell research, with a focus on spinal cord and traumatic brain injury, and research administration.

Contact

Biography

Dr. Anderson’s research is focused on two principal goals. First, investigating the interactions of transplanted stem cell populations within the injured niche, including the role of the evolving inflammatory microenvironment in neural stem cell fate and migration decisions. This work has recently revealed a role for novel neuroimmune signaling pathway in glioblastoma stem cell biology. Second, investigating the role of inflammatory mechanisms in degeneration and regeneration in the injured CNS; particularly the role of the innate immune response and application of biomaterials to promote functional regeneration. Research in Dr. Anderson’s laboratory bridges the junction between seeking to understand mechanism at the basic neuroscience level, and identifying translational neuroscience strategies to ameliorate the cellular and histopathological deficits associated with SCI to promote recovery of function.

Areas of Expertise

Glioblastoma
Stem Cell Biology
Stem Cell Research
Spinal Cord Injury

Accomplishments

UCI Chancellor's Award for Excellence in Research Mentorship

2006

Education

University of California, Irvine

PhD

Biology, Neurobiology

1996

University of Illinois, Urbana

BS

Bioengineering

1987

Affiliations

  • Society for Neuroscience
  • American Association for the Advancement of Science
  • International Society for Stem Cell Research

Media Appearances

Advancing regenerative medicine therapies

Newswise  online

2024-06-26

University and community guests recently gathered to celebrate the 7,700 square-foot Good Manufacturing Practice facility’s grand opening in Hewitt Hall’s basement on the UC Irvine campus. … “This facility is not just a building; it is a powerhouse of innovation and hope, meticulously designed and equipped to produce FDA-compliant cell and gene therapies, which are at the forefront of medical science’s promise for the future,” says Dr. Michael J. Stamos, dean of the UC Irvine School of Medicine. … “Our commitment to taking a multidisciplinary approach to integrating groundbreaking research with clinical applications was also recognized and supported by the California Institute for Regenerative Medicine,” says Aileen Anderson, Ph.D., director of the UC Irvine Stem Cell Research Center and professor of physical medicine & rehabilitation.

View More

Can We Rebuild the Spinal Cord? These Scientists Are Redefining What's Possible

Inverse  online

2023-03-02

After someone experiences a spinal cord injury, doctors set off on a race against the clock. … “The dominant thinking was that you should focus on acute injuries,” Aileen Anderson, a stem cell researcher [and professor] at the University of California, Irvine, tells Inverse. “If you could just hit a magic bullet at that stage and minimize the amount of damage that’s happening because it kind of rolls out over days and a couple of weeks … this was the place to target.” … Some teams, including Anderson and her colleagues, are trying to put specialized materials into people’s spinal cords, such as scaffolds made of hydrogels, as another method to help the spinal cord reconnect itself. It could also help to combine scaffolding and stem cells, Anderson says, an idea currently in the early stages of development.

View More

$5.5M grant awarded for spinal stem cell research

Becker's Spine Review  online

2021-12-01

"In the U.S., there are about 285,000 individuals living with paralysis due to traumatic spinal cord injury, and there are no FDA-approved treatments," Dr. Anderson said in a Nov. 30 news release. "Integrating transplanted human neural stem cells is likely to direct improved locomotor function, and increasing a single level of spine function can make a significant positive impact on both quality of life and the economic burden of disease for these patients."

View More

Show All +

Articles

Biomaterial Bridges Enable Regeneration and Re-Entry of Corticospinal Tract Axons Into the Caudal Spinal Cord After SCI: Association With Recovery of Forelimb Function

Biomaterials

2015

Severed axon tracts fail to exhibit robust or spontaneous regeneration after spinal cord injury (SCI). Regeneration failure reflects a combination of factors, including the growth state of neuronal cell bodies and the regeneration-inhibitory environment of the central nervous system. However, while spared circuitry can be retrained, target reinnervation depends on longitudinally directed regeneration of transected axons.

View more

Achieving Informed Consent for Cellular Therapies: A Preclinical Translational Research Perspective on Regulations Versus a Dose of Reality

J Law Med Ethics

2016

A central principle of bioethics is "subject autonomy," the acknowledgement of the primacy of the informed consent of the subject of research. Autonomy requires informed consent - the assurance that the research participant is informed about the possible risks and benefits of the research. In fact, informed consent is difficult when a single drug is being tested, although subjects have a baseline understanding of the testing of a pharmacological agent and the understanding that they can stop taking the drug if there were an adverse event.

View more

Systemic Neutrophil Depletion Modulates the Migration and Fate of Transplanted Human Neural Stem Cells to Rescue Functional Repair

J Neurosci

2017

The interaction of transplanted stem cells with local cellular and molecular cues in the host CNS microenvironment may affect the potential for repair by therapeutic cell populations. In this regard, spinal cord injury (SCI), Alzheimer's disease, and other neurological injuries and diseases all exhibit dramatic and dynamic changes to the host microenvironment over time.

View more

Show All +